Genetics, functions, and clinical impact of presenilin-1 (PSEN1) gene
Presenilin-1 (PSEN1) has been verified as an important causative factor for early onset
Alzheimer's disease (EOAD). PSEN1 is a part of γ-secretase, and in addition to amyloid …
Alzheimer's disease (EOAD). PSEN1 is a part of γ-secretase, and in addition to amyloid …
The genetics of Alzheimer's disease
Alzheimer's disease (AD) is a complex and heterogeneous neurodegenerative disorder,
classified as either early onset (under 65 years of age), or late onset (over 65 years of age) …
classified as either early onset (under 65 years of age), or late onset (over 65 years of age) …
The age factor in Alzheimer's disease
R Guerreiro, J Bras - Genome medicine, 2015 - Springer
Alzheimer's disease is the most common type of dementia, and it is characterized by a
decline in memory or other thinking skills. The greatest risk factor for Alzheimer's disease is …
decline in memory or other thinking skills. The greatest risk factor for Alzheimer's disease is …
[HTML][HTML] Doença de Alzheimer: hipóteses etiológicas e perspectivas de tratamento
With the increase in life expectancy registered in the past few decades, the prevalence of
various medical conditions related to aging has been observed, such as dementia and …
various medical conditions related to aging has been observed, such as dementia and …
Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease
C Patterson, JW Feightner, A Garcia, GYR Hsiung… - Cmaj, 2008 - Can Med Assoc
Background: In addition to nonmodifiable genetic risk factors, potentially modifiable factors
such as hypertension, hyperlipidemia and environmental exposures have been identified as …
such as hypertension, hyperlipidemia and environmental exposures have been identified as …
Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2
S Jayadev, JB Leverenz, E Steinbart, J Stahl, W Klunk… - Brain, 2010 - academic.oup.com
Mutations in presenilin 2 are rare causes of early onset familial Alzheimer's disease.
Eighteen presenilin 2 mutations have been reported, although not all have been confirmed …
Eighteen presenilin 2 mutations have been reported, although not all have been confirmed …
Redox signaling and metabolism in Alzheimer's disease
MI Holubiec, M Gellert… - Frontiers in Aging …, 2022 - frontiersin.org
Reduction and oxidation reactions are essential for biochemical processes. They are part of
metabolic pathways and signal transduction. Reactive oxygen species (ROS) as second …
metabolic pathways and signal transduction. Reactive oxygen species (ROS) as second …
Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders
Y Cai, SSA An, SY Kim - Clinical interventions in aging, 2015 - Taylor & Francis
Alzheimer's disease (AD) is the most common form of dementia. Mutations in the genes
encoding presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein have …
encoding presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein have …
Genetics of Alzheimer's disease: a centennial review
N Ertekin-Taner - Neurologic clinics, 2007 - Elsevier
Alzheimer's disease (AD) genetics may be one of the most prolifically published areas in
medicine and biology. Three early-onset AD genes with causative mutations (APP, PSEN1 …
medicine and biology. Three early-onset AD genes with causative mutations (APP, PSEN1 …
[HTML][HTML] A systematic review of familial Alzheimer's disease: Differences in presentation of clinical features among three mutated genes and potential ethnic …
YF Shea, LW Chu, AOK Chan, J Ha, Y Li… - Journal of the Formosan …, 2016 - Elsevier
There are great diversities of clinical phenotypes among the various familial Alzheimer's
disease (FAD) families. We aimed to systematically review all the previously reported cases …
disease (FAD) families. We aimed to systematically review all the previously reported cases …